Invex Therapeutics Ltd
ASX:IXC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
Bravada Gold Corp
OTC:BGAVF
|
CA |
|
R
|
Royal Bank of Canada
XMUN:RYC
|
CA |
|
KDDI Corp
TSE:9433
|
JP |
|
D
|
Definitive Healthcare Corp
NASDAQ:DH
|
US |
|
E
|
Evonik Industries AG
SWB:EVK
|
DE |
|
D
|
Digistar Corporation Bhd
KLSE:DIGISTA
|
MY |
|
T
|
Taesung Co Ltd
KOSDAQ:323280
|
KR |
|
BACHEM HOLDING AG
LSE:0QND
|
CH |
|
I
|
Impresa Sociedade Gestora de Participacoes Sociais SA
ELI:IPR
|
PT |
Dividends
Dividend Yield
Invex Therapeutics Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Invex Therapeutics Ltd
IXC have decreased by 0%.
Payout Ratio
Invex Therapeutics Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for IXC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IXC Price
Invex Therapeutics Ltd
| Average Annual Return | -9.74% |
| Standard Deviation of Annual Returns | 59.88% |
| Max Drawdown | -92% |
| Market Capitalization | 8.6m AUD |
| Shares Outstanding | 75 150 000 |
| Percentage of Shares Shorted |
N/A
|
